Table 5.
AMR Gen | Study ID | Pathogen | HN | HI | Prevalance_H | AN | AI | Prevalnce_A_ | RR | 95%CI | Lab Technique |
---|---|---|---|---|---|---|---|---|---|---|---|
blaAMPc | Besharati et al., 2020 and Elhariri et al., 2020 | NTS and S. H | 99 | 13 | 13.13% | 31 | 1 | 3.23% | 0.34 | [0.07; 1.72] | PCR |
AAC(6’)-Ib | Youssef et al., 2021 | NTS | 50 | 8 | 16.00% | 50 | 11 | 22.00% | 1.38 | [0.6; 3.13] | PCR |
bla CMY-2 | Elhariri et al., 2020 | S. H | 24 | 9 | 37.50% | 9 | 1 | 11.11% | 0.3 | [0.04; 2.02] | PCR |
bla CTXM-1 | Youssef et al., 2021 | NTS | 50 | 8 | 16.00% | 50 | 11 | 22.00% | 1.38 | [0.6; 3.13] | PCR |
bla OXA | Elhariri et al., 2020 | S. H | 24 | 5 | 20.83% | 9 | 1 | 11.11% | 0.53 | [0.07; 3.96] | PCR |
PCR | |||||||||||
bla OXA-61 | Divsalar et al., 2019 | C. jejuni | 80 | 42 | 52.50% | 20 | 7 | 35.00% | 0.67 | [0.35; 1.25] | PCR |
bla SHV | Youssef et al., 2021 and Elhariri et al., 2020 | NTS and S. H | 74 | 14 | 18.92% | 59 | 12 | 20.34% | 1.13 | [0.49; 2.61] | PCR |
blaTEM | Youssef et al., 2021, Besharati et al., 2020 and Elhariri et al., 2020 | NTS, NTS, and S. H | 149 | 19 | 12.75% | 81 | 12 | 14.81% | 0.91 | [0.34; 2.44] | PCR |
Class 1 Integrons | Besharati et al., 2020 and AbdEl-Aziz et al., 2020 | NTS and C. jejuni | 223 | 180 | 80.72% | 42 | 29 | 69.05% | 1.04 | [1.01; 1.08] | PCR |
class 2 Integrons | Besharati et al., 2020 | NTS | 75 | 22 | 29.33% | 22 | 6 | 27.27% | 0.93 | [0.43; 2] | PCR |
cme B | Divsalar et al., 2019 | C. jejuni | 80 | 41 | 51.25% | 20 | 7 | 35.00% | 0.68 | [0.36; 1.29] | PCR |
tet(A) | Divsalar et al., 2019 | C. jejuni | 80 | 17 | 21.25% | 20 | 6 | 30.00% | 1.41 | [0.64; 3.11] | PCR |
tet(O) | Divsalar et al., 2019 and Ghoneim et al., 2020 | C. jejuni | 84 | 71 | 84.52% | 22 | 17 | 77.27% | 0.92 | [0.73; 1.16] | PCR |
HN: Number of human isolates: HI: human isolates that have this gene; prevalance_H: prevalence among human isolates; AN: number of animal isolates; AI: animal isolates that have this gene; prevalance_A: prevalence among animal isolates; RR: relative risk; NTS: non-typhoidal Salmonella; S.H: Salmonella Heidelberg; C. jejuni: Campylobacter jejuni.